Distribution of Pupil Size and Associated Factors: Results from the Population-Based Gutenberg Health Study.

Authors:
Kiel M; Grabitz SD; Hopf S; Koeck T; Wild PS and 6 more

Journal:
J Ophthalmol

Publication Year: 2022

DOI:
10.1155/2022/9520512

PMCID:
PMC9481399

PMID:
36119137

Journal Information

Full Title: J Ophthalmol

Abbreviation: J Ophthalmol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Ophthalmology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of Interest The authors declare that they have no conflicts of interest. There are no patents, products in development, or marketed products to declare. This does not alter the authors' adherence to all the journal policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Beutel ME received speaker honorarium from Pfizer Deutschland GmbH."

Evidence found in paper:

"The authors thank all study participants for their willingness to provide data for this research project and the authors are indebted to all coworkers for their enthusiastic commitment. The authors also thank the Government of Rhineland-Palatinate (“Stiftung Rheinland-Pfalz für Innovation,” contract AZ 961-386261/733) for their funding, the research programs “Wissen schafft Zukunft,” and “Center for Translational Vascular Biology (CTVB)” of the Johannes Gutenberg-University of Mainz and Boehringer Ingelheim and PHILIPS Medical Systems, including an unrestricted grant for the Gutenberg Health Study. Boehringer Ingelheim, PHILIPS Medical Systems, Heidelberg Engineering, and Novartis Pharma provided funding toward this study. The Gutenberg Health Study is funded through the government of Rhineland-Palatinate (“Rheinland-Pfalz für Innovation,” contract AZ 961-386261/733), the research programs “Wissen schafft Zukunft” and “Center for Translational Vascular Biology (CTVB)” of the Johannes Gutenberg-University of Mainz, and its contract with Boehringer Ingelheim and PHILIPS Medical Systems, including an unrestricted grant for the Gutenberg Health Study. Schuster AK holds the professorship for ophthalmic healthcare research endowed by “Stiftung Auge” and financed by “Deutsche Ophthalmologische Gesellschaft” and “Berufsverband der Augenärzte Deutschland e.V.” Pfeiffer N receives financial support by Novartis, Ivantis, Santen, Thea, Boehringer Ingelheim Deutschland GmbH & Co. KG, Alcon, and Sanoculis. Shire Deutschland GmbH and currently receives research grants from the governments of Rhineland-Palatinate and Nordrhein-Westfalen, the German Association of Psychoanalysis and Psychotherapy (DGPT), the German Research Foundation, the German Ministry of Research, the German Cancer Aid, and the European Union. Pfeiffer N receives financial support and grants from Novartis, Ivantis, Santen, Thea, Boehringer Ingelheim Deutschland GmbH & Co. KG, Alcon, and Sanoculis. Schuster AK received research funding from Allergan, Bayer Vital, Novartis, PlusOptix, and Heidelberg Engineering."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025